Guoqing Chen
Chief Executive Officer at Advenchen Laboratories LLC
Profile
Guoqing Chen is the founder of Igenica Biotherapeutics, Inc. founded in 2008.
He is currently the Chief Executive Officer at Advenchen Laboratories LLC.
Dr. Chen's former positions include Director at Elevar Therapeutics, Inc., Senior Scientist at Amgen, Inc., and Scientist at Tularik, Inc. He holds a doctorate degree from the University of California, Los Angeles.
Guoqing Chen active positions
| Companies | Position | Start |
|---|---|---|
Advenchen Laboratories LLC
 Advenchen Laboratories LLC Medical SpecialtiesHealth Technology Advenchen Laboratories LLC operates as a pharmaceutical company. It focuses on pharmaceutical research and development involving small molecule cancer drug discovery programs. The firm’s proprietary drug development product pipeline has demonstrated anti-tumor activities and therapeutic benefits. The company is headquartered in Moorpark, CA. | Chief Executive Officer | - |
Former positions of Guoqing Chen
| Companies | Position | End |
|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Founder | - |
Training of Guoqing Chen
| University of California, Los Angeles | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 4 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Advenchen Laboratories LLC
Advenchen Laboratories LLC Medical SpecialtiesHealth Technology Advenchen Laboratories LLC operates as a pharmaceutical company. It focuses on pharmaceutical research and development involving small molecule cancer drug discovery programs. The firm’s proprietary drug development product pipeline has demonstrated anti-tumor activities and therapeutic benefits. The company is headquartered in Moorpark, CA. | Health Technology |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
- Stock Market
- Insiders
- Guoqing Chen
